据彭博社周五报道,本周香港两家大型股票上市后的强劲表现引发人们的希望,即一小部分中国顶尖公司可能开始推动一场变革,结束香港股市多年来相对于内地市场的折价现象。最新加入这一行列的是江苏恒瑞医药股份有限公司,该公司是中国市值最大的制药商。周五,该公司在香港上市首日飙升37%,募集资金99亿港元(合13亿美元)。该公司H股一度较其在上海证券交易所上市的A股溢价0.3%,随后回落至折价4%。此前,电池巨头...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.